Bavarian Nordic AS (OTCPK:BVNRY)
$ 9.48 +0.15 (+1.66%) Market Cap: 2.15 Bil Enterprise Value: 1.82 Bil PE Ratio: 12.04 PB Ratio: 1.14 GF Score: 79/100

Q4 2025 Bavarian Nordic A/S Earnings Call Transcript

Mar 12, 2026 / 01:00 PM GMT
Release Date Price: $9.11 (-4.95%)

Key Points

Positve
  • Bavarian Nordic AS (BVNKF) reported strong financial results for 2025, with a revenue of 6.2 billion Danish krona and an EBITDA margin of 28%.
  • The company experienced a 30% growth in its travel health segment, driven by the successful launch of the chikungunya vaccine.
  • Bavarian Nordic AS (BVNKF) secured significant contracts in public preparedness, resulting in revenues exceeding 3.1 billion Danish krona, which is above the upper end of their normal base business.
  • The company announced strategic partnerships to expand the distribution of its chikungunya vaccine in Brazil and India, enhancing market access.
  • Bavarian Nordic AS (BVNKF) has a strong cash position with 3.3 billion Danish krona in cash and no debt, supporting its financial stability and future growth initiatives.
Negative
  • The company anticipates a decrease in total revenue for 2026, guiding between 5 and 5.2 billion Danish krona, reflecting a more normalized year for public preparedness.
  • There are uncertainties regarding the shelf life of certain vaccines, which could impact future sales if not extended beyond the current 12 months.
  • Bavarian Nordic AS (BVNKF) faces challenges in expanding the shelf life of its tick-borne encephalitis vaccine, which currently has a limited shelf life compared to the product acquired from GSK.
  • The company is experiencing increased SG&A expenses due to strategic expansions and the launch of new products, which could pressure margins.
  • There is a delay in the clinical start of pipeline projects for Lyme disease and Epstein-Barr virus, which may impact future R&D spending and project timelines.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BAVA.CO - Bavarian Nordic A/S
Q4 2025 Bavarian Nordic A/S Earnings Call
Mar 12, 2026 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and thank you for standing by. Welcome to the Bavaria Nordic 2025 annual report.

At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the presentation, you will need to press 1 and 1 on your telephone, and you will then hear an automated message advising your hand is raised. To withdraw your question, you can press one and one again.

Please be advised today's conference is being recorded. I'd now like to hand the conference over to your first speaker today, CEO Paul Chaplin. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot